Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 4 1

Status

Completed 3Withdrawn 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Tumor-Agnostic 5Breast 4Other hematologic neoplasm 3Lymphoid 3Plasma cell 2Gastrointestinal 2Sarcoma 1Other solid neoplasm 1Dermatologic 1CNS 1

Conditions

Vomiting 2Nausea 2Lymphoma 2Neoplasms 1Multiple Myeloma 1Lymphoma, Non-Hodgkin 1Leukemia 1

Interventions

Rituximab 702Cyclophosphamide 645Vincristine 353Doxorubicin 309Etoposide 305Cytarabine 271Filgrastim 250Prednisone 249Methotrexate 241fludarabine phosphate 231Dexamethasone 209fludarabine 184Peripheral Blood Stem Cell Transplantation 166Radiotherapy 161Granulocyte Colony-Stimulating Factor 145Lenalidomide 144Bendamustine Hydrochloride 142Bortezomib 127Melphalan 126ibrutinib 111Busulfan 111Mycophenolic Acid 108Whole-Body Irradiation 107Tacrolimus 96Cyclosporine 87Gemcitabine 82Ifosfamide 80Calcium Dobesilate 80Alemtuzumab 80Leucovorin 78

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Palonosetron × Lymphoid × Clear all
NCT00600353 2017-03-09

Multi-day Doses in Prevention of Nausea and Emesis

University of Kansas Medical Center

Phase 2 Completed
20 enrolled 8 charts
LymphoidPlasma cell

Lymphoma, Multiple Myeloma, Nausea, Neoplasms

NCT01018758 2009-11-25

NHLPal

Gruppo Italiano Studio Linfomi

Phase 2 Completed
86 enrolled
Lymphoid

Lymphoma, Non-Hodgkin, Vomiting

NCT00415103 2009-09-18

AMENO-2

PETHEMA Foundation

Phase 4 Completed
196 enrolled
LymphoidOther hematologic neoplasm

Leukemia, Lymphoma, Nausea, Vomiting

Data powered by HemOnc (CC BY 4.0) Colophon âš¡